DRH-PHARMA's advanced research division focuses on three main areas: novel drug discovery, advanced formulation development, and biotechnology research.
Our research capabilities include high-throughput screening, computational chemistry, molecular modeling, and pre-clinical studies. We maintain GLP-compliant laboratories equipped with sophisticated analytical instruments including HPLC, GC-MS, and LC-MS/MS.
Through strategic collaborations with academic institutions and research organizations, we continuously push the boundaries of pharmaceutical science.
Our key research achievements include novel extended-release technologies, innovative drug delivery systems, and the discovery of new therapeutic candidates for chronic diseases.
We remain dedicated to advancing medical science and bringing transformative treatments to patients globally.